Clinical Trial Update: Melatonin in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating melatonin in breast cancer patients undergoing neoadjuvant chemotherapy. The study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Mansoura University | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING